SMI
|
11 910,60
|
101,89
|
0,86%
|
Analysen zu SMI-Werten
| 02.05.24 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.24 | Nestlé Buy | Deutsche Bank AG | |
| 29.04.24 | Nestlé Kaufen | DZ BANK | |
| 26.04.24 | Nestlé Buy | UBS AG | |
| 26.04.24 | Nestlé Add | Baader Bank | |
| 26.04.24 | Holcim Hold | Deutsche Bank AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.24 | Nestlé Add | Baader Bank | |
| 25.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.04.24 | Nestlé Buy | Deutsche Bank AG | |
| 25.04.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | Roche Neutral | UBS AG | |
| 25.04.24 | Roche Equal Weight | Barclays Capital | |
| 25.04.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.24 | Roche Kaufen | DZ BANK | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | UBS Outperform | RBC Capital Markets | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | ABB Hold | Deutsche Bank AG | |
| 23.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 23.04.24 | UBS Underweight | Barclays Capital | |
| 22.04.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.04.24 | ABB Hold | Deutsche Bank AG | |
| 19.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 19.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | ABB Kaufen | DZ BANK | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.